Immune checkpoint inhibitors (anti PD‐1 or anti PD‐L1) versus chemotherapy for second‐ or third‐line treatment of metastatic non‐small cell lung cancer
免疫检查点抑制剂（抗PD-1或抗PD-L1）与化疗在转移性非小细胞肺癌二线或三线治疗中的比较
期刊:npj Primary Care Respiratory Medicine
影响因子:4.7
doi:10.1038/s41533-019-0128-8
Inoue, Hiromasa; Kozawa, Masanari; Milligan, Ki Lee; Funakubo, Minako; Igarashi, Ataru; Loefroth, Emil; Moraes, Fabio Y; Perry, Luke A; Penny‐Dimri, Jahan C; Ramson, Dhruvesh; de Castria, Tiago B; Bowman, Rayleen V; Santos, Fábio N; Fong, Kwun M; Riera, Rachel
肺癌
肿瘤
肿瘤免疫
PD-L1
细胞生物学
PD-1
免疫/内分泌
